Evidence map›Paper›PMID 31959994›Full record

ArticleNature genetics2020

Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation.

Anindita Basak, Mathias Munschauer, Caleb A Lareau, Kara E Montbleau, Jacob C Ulirsch, Christina R Hartigan, Monica Schenone, John Lian, Yaomei Wang, Yumin Huang and 11 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New Gene Therapy Strategy for β-Thalassemia.Stem cell reviews and reports · 2026
    Review
  5. Article
  6. Article
  7. Dissecting polycomb complexes for enhanced fetal hemoglobin production.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Cell type-specific purifying selection of synonymous mitochondrial DNA variation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Anindita Basak *Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. abasak@broadinstitute.org.ORCID http://orcid.org/0000-0002-7046-4500
Mathias Munschauer *Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6143-4548
Caleb A LareauDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Kara E MontbleauDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Jacob C UlirschDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7947-0827
Christina R HartiganBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
Monica SchenoneBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6456-8768
John LianInstitute for Biomedical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Yaomei WangNew York Blood Center, New York, NY, USA.
Yumin HuangNew York Blood Center, New York, NY, USA.
Xianfang WuThe Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Lee GehrkeInstitute for Biomedical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Charles M RiceThe Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Xiuli AnNew York Blood Center, New York, NY, USA.
Helen A ChristouDepartment of Pediatric Newborn Medicine, Brigham and Women's Hospital and Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Narla MohandasNew York Blood Center, New York, NY, USA.
Steven A CarrBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-7203-4299
Jane-Jane ChenInstitute for Biomedical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4372-6907
Stuart H OrkinDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Eric S LanderBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2662-4631
Vijay G SankaranDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. sankaran@broadinstitute.org.ORCID http://orcid.org/0000-0003-0044-443X
Broad Institute · USNew York Blood Center · USHarvard–MIT Division of Health Sciences and Technology · USRockefeller University · USBrigham and Women's Hospital · US

Funding

YEAST MEMBRANE CYTOSKELETONP01DK032094 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1987 to 2021
$26.7M
MOLECULAR ANALYSIS OF NORMAL AND TYHALASSEMIC DNAR01HL032259 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2022
$8.8M
Translational and clinical studies targeting y-globin modulationU01HL117720 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI SANKARAN, VIJAY GANESH · 2013 to 2017
$7.4M
Systematic Genetic Dissection of Human ErythropoiesisR01DK103794 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Vijay Ganesh Sankaran · 2014 to 2026
$5.9M
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and ErythropoiesisR01DK087984 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JANE-JANE · 2010 to 2017
$2.1M
Identifying Genome-wide Association Study-Nominated Regulators of ErythropoiesisR33HL120791 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI SANKARAN, VIJAY GANESH · 2016 to 2018
$1.7M
NHLBI NIH HHS R01 HL032259NHLBI NIH HHS R33 HL120791NHLBI NIH HHS U01 HL117720NIDDK NIH HHS P01 DK032094NIDDK NIH HHS R01 DK087984NIDDK NIH HHS R01 DK103794
6 · The paper itself

Abstract

Increased production of fetal hemoglobin (HbF) can ameliorate the severity of sickle cell disease and β-thalassemia

Indexed as

AdultAnimalsBinding SitesCells, CulturedErythroid CellsErythropoiesisGene Expression RegulationHemoglobinsHumansInfant, NewbornMicroRNAsProtein BiosynthesisRepressor ProteinsRibosomesRNA-Binding ProteinsRNA, MessengerBCL11A protein, humanHemoglobinsLIN28B protein, humanMicroRNAsmirnlet7 microRNA, humanRepressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA, Ribosomal, 18S

Identifiers

PMID31959994
PMCPMC7031047
OpenAlexW2998852785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.